AHR insider sells 1,500 shares at $49.3531 avg; 57,600 held

American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).

Accepted by SEC EDGAR 11/12/2025 - 04:58 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

American Healthcare REIT (AHR) executive Mark E. Foster (EVP, GC & Secretary) reported an open-market sale of 1,500 shares of common stock on 11/11/2025 at a $49.3531 weighted average price (Transaction Code: S).

The sale was executed in multiple trades between $49.35 and $49.37. Following the transaction, Foster beneficially owns 57,600 shares directly.

Insider Trade Summary

Net Seller: 1,500 shares

Net Sell 1 txn

Insider Foster Mark E.

Role EVP, GC & Secretary

Sold 1,500 shs ($74K)

Share of Position Sold 2.5%

Type	Security	Shares	Price	Value
Sale	Common Stock	1,500	$49.3531	$74K

Holdings After Transaction: Common Stock — 57,600 shares (Direct)

Holdings Before and After: Common Stock, 59,100 to 57,600 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $49.3500 to $49.3700, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth herein.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AHR report?

AHR reported that Mark E. Foster sold 1,500 shares of common stock on 11/11/2025.

At what price were the AHR shares sold?

The sale was at a $49.3531 weighted average price, with trades ranging from $49.35 to $49.37.

How many AHR shares does the insider hold after the sale?

After the transaction, Mark E. Foster beneficially owns 57,600 shares directly.

What was the Form 4 transaction code for the AHR trade?

The transaction code was S, indicating an open-market or private sale of non-derivative securities.

What is the insider’s role at American Healthcare REIT (AHR)?

Mark E. Foster is AHR’s EVP, General Counsel & Secretary.

Were the AHR sales executed as multiple trades?

Yes. The filing notes multiple trades within the $49.35–$49.37 range on the same date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foster Mark E.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CA 92612

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		S		1,500	D	$49.3531(1)	57,600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $49.3500 to $49.3700, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth herein.

	/s/ MARK E. FOSTER	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.